This is the first time I have come to India. I am very impressed with what I have seen. I am looking at the possibility of putting up a facility here.

Dr Anwar Nasim
Advisor Science, COMSTECH Secretariat, Pakistan

Pakistan is not as strong as India in vaccines. I see a lot of collaboration potential in this area between the two countries.

G Michael Alder
MD, Redmont Venture Partners Inc & Executive Director Biotechnology Association of Alabama, USA

My perception of India has changed considerably after coming here. I no longer see India as I see Thailand, Malaysia, China or any other SouthEast Asian country.

Dr Santosh K Mishra
Executive Director, BioInformatics Institute, Singapore

India has a great strength in IT and making huge strides in bioinformatics is just the next logical step.

Govindaluri Anand
Associate Director, Investments, Temasek Holdings, Singapore

We are already investors in some of the companies here and I am scouting for more investment opportunities. I see a lot of potential in Hyderabad in the pharma biotech.

Dr Pravin Kini
MD & CSO, CytoGenomics Inc, Chesterfied, USA

It is a good platform for networking except that three-days is a way too long for any event. It should be a one-day event.

Dr Krishna Menon
COO, Kard Scientific, Cambridge, USA

I am glad that I am here. It has been a very productive event in terms of networking and getting to know the biotechnology industry in India.

Dr Vasudeo Ginde
MD, iGate Clinical Research International, Mumbai, India

I would say we need to be extremely quality conscious while taking advantage of this big opportunity of clinical trials. The cost of failing on that count will be very high. Let us not fail even once.

"